KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,040
-140 (-1.15%)
At close: Apr 20, 2026
Market Cap129.68B -20.8%
Revenue (ttm)87.60B +7.8%
Net Income-2.64B
EPS-242.00
Shares Out10.91M
PE Ration/a
Forward PEn/a
Dividend50.00 (0.44%)
Ex-Dividend DateDec 29, 2025
Volume22,662
Average Volume21,316
Open11,970
Previous Close12,180
Day's Range11,910 - 12,160
52-Week Range10,780 - 18,710
Beta0.85
RSI55.43
Earnings Daten/a

About KOREA PHARMA

KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1974
Employees 134
Stock Exchange KOSDAQ
Ticker Symbol 032300
Full Company Profile

Financial Performance

Financial Statements